Streetbeat News

Regulatory

USO

OPEC nations are likely to take action as short selling mounts, according to a Reuters report citing Stanchart. The US-listed ETF USO may be impacted by this news.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 3:03 pm

ORCL

TikTok claims its US survival plan is progressing, but its cloud provider, Oracle, has doubts as they haven't reached an agreement on monitoring the app.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 2:33 pm

SPY

A Federal Reserve survey reveals that U.S. households have reported a decline in financial well-being, with higher prices negatively affecting most households.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 2:32 pm

KRYS

Krystal Biotech shares are trading higher after the company received FDA approval for VYJUVEK last week.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 2:30 pm

BITC

BITW

GBTC

The SEC remains cautious about approving a Spot Price Bitcoin ETF due to market manipulation concerns. Despite this, several ETFs and investment vehicles have emerged to provide investors with exposure to cryptocurrencies, including Grayscale Bitcoin Trust (OTC:GBTC), Purpose Bitcoin ETF (BTCC), VanEck Vectors Bitcoin Strategy ETF, Bitwise 10 Crypto Index Fund (OTC:BITW), CoinShares Physical Bitcoin (NYSE:BITC), and 3iQ CoinShares Bitcoin ETF.

Portfolio Pulse from Jeffrey Kamys

May 22, 2023 | 2:25 pm

CVX

META

MU

UBER

XOM

Meta faces a record $1.3B penalty for data privacy violation, Uber's diversity leader is suspended amid racism complaints, and China bans some of Micron's product sales. Exxon explores lithium production, and Chevron acquires PDC Energy in a $7.6B deal.

Portfolio Pulse from Vandana Singh

May 22, 2023 | 2:21 pm

SPY

The original tweet reporting a Pentagon explosion has been removed from Twitter. The reason for the removal is unclear.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 2:19 pm

SPY

U.S. President Biden and House Speaker McCarthy are scheduled to meet at 5:30 p.m. to discuss the debt ceiling, according to the White House.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 2:18 pm

NVO

Novo Nordisk announced positive results from the OASIS 1 trial, a phase 3a trial for oral semaglutide 50 mg in obesity treatment. The trial demonstrated a statistically significant weight loss of 15.1% compared to 2.4% with placebo. The company expects to file for regulatory approval in the US and EU in 2023.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 2:13 pm

AKBA

Akebia Therapeutics announced that the UK MHRA has approved Vafseo for the treatment of symptomatic anemia associated with chronic kidney disease in adults on chronic maintenance dialysis. This news has led to an increase in Akebia's share price.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 2:11 pm